Tina Nova, Ph.D., is a life sciences entrepreneur and executive. She co-founded Genoptix Medical Laboratory and served as its President and CEO, taking it public before Novartis acquired it in 2011 for $470 million.

She later served as President and CEO of Molecular Stethoscope and of Decipher Biosciences, which Veracyte acquired in 2021 for $600 million. Earlier in her career she held executive roles at Illumina, Nanogen, Ligand Pharmaceuticals and Hybritech.

She holds a Ph.D. in biochemistry from UC Riverside and a B.S. in biological sciences from UC Irvine, and was named one of FierceBiotech’s Top 10 Women in Biotech in 2011. She serves on the boards of Truvian Health, Azenta and Exagen.

Tina Nova is one of the WEDO 2024 Pioneer Honorees and is featured in the lineup for the WEDO2024 Summit. Learn more about the Women’s Entrepreneurship Day Organization (WEDO).